BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8595123)

  • 1. Sequence-specific DNA interactions by novel alkylating anthracycline derivatives.
    Marchini S; Gonzalez Paz O; Ripamonti M; Geroni C; Bargiotti A; Caruso M; Todeschi S; D'Incalci M; Broggini M
    Anticancer Drug Des; 1995 Dec; 10(8):641-53. PubMed ID: 8595123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective DNA interaction of the novel distamycin derivative FCE 24517.
    Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
    Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards.
    McClean S; Costelloe C; Denny WA; Searcey M; Wakelin LP
    Anticancer Drug Des; 1999 Jun; 14(3):187-204. PubMed ID: 10500495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles.
    Atwell GJ; Fan JY; Tan K; Denny WA
    J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents.
    Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
    Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards.
    Turner PR; Denny WA; Ferguson LR
    Anticancer Drug Des; 2000 Aug; 15(4):245-53. PubMed ID: 11200500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, DNA binding and cytotoxicity of 1-[[omega-(9-acridinyl)amino]alkyl]carbonyl -3-(chloromethyl)-6-hydroxyindolines, a new class of DNA-targeted alkylating agents.
    Fan JY; Tercel M; Denny WA
    Anticancer Drug Des; 1997 Jun; 12(4):277-93. PubMed ID: 9199660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the DNA-DNA cross-linking activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin.
    Jesson MI; Johnston JB; Robotham E; Begleiter A
    Cancer Res; 1989 Dec; 49(24 Pt 1):7031-6. PubMed ID: 2531036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of new bifunctional compounds which selectively alkylate guanines in DNA.
    Henderson ND; Lacy SM; O'Hare CC; Hartley JA; McClean S; Wakelin LP; Kelland LR; Robins DJ
    Anticancer Drug Des; 1998 Oct; 13(7):749-68. PubMed ID: 9807160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstrand DNA-DNA and DNA-protein cross-links by a new antitumor antibiotic, FK973, in L1210 cells.
    Masuda K; Nakamura T; Mizota T; Mori J; Shimomura K
    Cancer Res; 1988 Sep; 48(18):5172-7. PubMed ID: 3409243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA minor groove targeted alkylating agents based on bisbenzimidazole carriers: synthesis, cytotoxicity and sequence-specificity of DNA alkylation.
    Smaill JB; Fan JY; Denny WA
    Anticancer Drug Des; 1998 Dec; 13(8):857-80. PubMed ID: 10335264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA sequence selectivity of guanine-N7 alkylation by three antitumor chloroethylating agents.
    Hartley JA; Gibson NW; Kohn KW; Mattes WB
    Cancer Res; 1986 Apr; 46(4 Pt 2):1943-7. PubMed ID: 3004713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
    Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.
    Marchini S; Damia G; Broggini M; Pennella G; Ripamonti M; Marsiglio A; Geroni C
    Cancer Res; 2001 Mar; 61(5):1991-5. PubMed ID: 11280757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
    Coley HM; Mongelli N; D'Incalci M
    Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards.
    Balcome S; Park S; Quirk Dorr DR; Hafner L; Phillips L; Tretyakova N
    Chem Res Toxicol; 2004 Jul; 17(7):950-62. PubMed ID: 15257621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation.
    Gupta R; Liu J; Xie G; Lown JW
    Anticancer Drug Des; 1996 Dec; 11(8):581-96. PubMed ID: 9022747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alkylating antitumor drug tallimustine does not induce DNA repair.
    Rossi R; Montecucco A; Capolongo L; Mezzina M; Chevallier-Lagente O; Sarasin A; Ciarrocchi G
    Anticancer Res; 1996; 16(6B):3779-83. PubMed ID: 9042257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry studies of the binding of the minor groove-directed alkylating agent alkamin to AT-tract oligonucleotides.
    Abdul Majid AM; Smythe G; Denny WA; Wakelin LP
    Chem Res Toxicol; 2009 Jan; 22(1):146-57. PubMed ID: 19113942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antitumor bifunctional DNA alkylating agents, synthesis and biological activities of 3a-aza-cyclopenta[a]indenes.
    Kakadiya R; Dong H; Lee PC; Kapuriya N; Zhang X; Chou TC; Lee TC; Kapuriya K; Shah A; Su TL
    Bioorg Med Chem; 2009 Aug; 17(15):5614-26. PubMed ID: 19576785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.